Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The UK Pandemic Ethics Accelerator, which launched today, harnesses and mobilises the UK’s internationally renowned expertise in ethics research. Four major UK universities and the Nuffield Council on Bioethics form the collaborative.

Macro photo of tooth wheel mechanism with CORE VALUES, TRUST, ETHICS, INNOVATION, RELIABILITY and TEAMWORK concept words

The collaborative has received £1.4M funding from the Arts and Humanities Research Council (AHRC) as part of the UK Research and Innovation rapid response to COVID-19.

The COVID-19 crisis has demanded that policy-makers, researchers, health and social care workers, and members of the public address unprecedented ethical dilemmas every day. The complexity and speed by which the challenges from COVID-19 arise lead to harms on a significant scale, some of which are inevitable while some may be avoidable.

The Accelerator provides rapid evidence, guidance and critical analysis to inform policy and help improve decision-making. It also supports, informs and promotes public debate around key ethical challenges, and ensures that ethical thinking is embedded at the core of future pandemic preparedness.

By coordinating and focusing national investment in ethics research, the initiative will maximise the impact of ethical considerations across science, medicine, policy and society. This approach should help improve transparency and accountability, and improve public trust in decision-makers.

The collaborative’s Principal Investigator, Ilina Singh, Professor of Neuroscience & Society in the Department of Psychiatry and Co-Director of the Wellcome Centre for Ethics & Humanities at the University of Oxford, said:

 

 

'This pandemic has raised enormous challenges that require world-leading science together with world-leading ethics to enable public trust and accountability. We are a vital partner in the UK’s COVID-19 research response infrastructure, ensuring it can be guided by both ethical and scientific considerations. We have already helped to inform discussion around mass testing for COVID-19 and vaccine prioritisation, and we are now identifying issues and supporting ethical decision-making across public health, policy, medicine and education. We know that the burden of responsibility and accountability for making everyday decisions has become a real source of anxiety for people, so we will engage members of the public so we can learn how to support them best. The collaborative is also thinking ahead to what the post-COVID pandemic landscape will look like, so we can anticipate and help mitigate the structural inequalities it has laid bare.'

The Accelerator will initially address five key themes:

  • Data use: ethical challenges arising from large-scale data collection, access, and use, such as those arising from the NHS tracking app and vaccine certification.
  • Foresight: ethical challenges arising from the current pandemic such as vaccine passports, and preparedness for future pandemic crises.
  • Prioritisation: the values informing access to resources, such as vaccine distribution and treatment triaging policies, the deployment of mass testing, and the use of public health interventions such as quarantine.
  • Public health and health inequalities: identifying values and ethical challenges to inform equitable policy and practice, given that the direct and indirect impacts of covid-19 have both underscored and exacerbated structural health inequalities.
  • Public values, transparency and governance: ensuring public attitudes and engagements inform policy-making when individuals’ and societies’ core interests and values, including health, well-being, equity, social justice and liberty, are at stake.

 

The UK Pandemic Ethics Accelerator Co-Investigators are:

  • University of Bristol: Professor John Coggon
  • University of Edinburgh: Dr Sarah Chan and Professor Sarah Cunningham-Burley
  • University of Oxford: Professors Dominic Wilkinson and Julian Savulescu
  • University College London: Dr Melanie Smallman and Professor James Wilson
  • Nuffield Council on Bioethics: Hugh Whittall

For more information about the UK Pandemic Ethics Accelerator and to follow on twitter.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Messaging Focused on Personal Rather Than Collective Benefits is More Effective for COVID-19 Vaccination

COVID-19

The largest ever study of COVID-19 vaccine messaging shows that emphasising the personal benefits of vaccination may be the most effective way to persuade people who are sceptical about the jab.

Future-Proofing Mental Health

COVID-19 Early intervention Mental Health

UK academics are calling for targets for mental health research in order to meet the healthcare challenges of the next decade. Published today in Journal of Mental Health, researchers set out four overarching goals that will speed up implementation of mental health research and give a clear direction for researchers and funders to focus their efforts when it comes to better understanding the treatment of mental health.

Children and Adolescents’ Mental Health: One Year On

COVID-19 Child and adolescent Mental Health

Parents and carers reported that behavioural, emotional and attentional difficulties in their children changed considerably throughout the past year, increasing in times of national lockdown and decreasing as restrictions eased and schools reopened, according to the latest Co-SPACE (COVID-19 Supporting Parents, Adolescents, and Children in Epidemics) study, led by experts at the University of Oxford.

Risk of Rare Blood Clotting Higher for COVID-19 than for Vaccines

COVID-19

Researchers at the University of Oxford have today reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza.

No Evidence of Significant Increase in Risk of Suicide in First Months of Pandemic

COVID-19 Mental Health Suicide

A new observational study is the first to examine suicides occurring during the early phase of the COVID-19 pandemic in multiple countries and finds that suicide numbers largely remained unchanged or declined in the pandemic’s early months, however continued monitoring is needed.

Largest study to date suggests link between COVID-19 infection and subsequent mental health and neurological conditions

COVID-19 Mental Health

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates.